Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of €63.59 billion as of December 5, 2025. Its market cap has decreased by -18.01% in one year.

Market Cap

63.59B

Enterprise Value

49.85B

Revenue

12.14B

Ranking

n/a

PE Ratio

16.30

Stock Price

€622.80

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 63.59B, an increase of 48,291.19%. That is a compound annual growth rate of 20.33%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	63.59B	-14.10%
Dec 31, 2024	74.03B	-12.40%
Dec 29, 2023	84.50B	17.20%
Dec 30, 2022	72.10B	24.19%
Dec 31, 2021	58.06B	39.28%
Dec 31, 2020	41.68B	13.96%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Erste Group Bank AG	37.86B
VERBUND AG	22.44B
OMV Aktiengesellschaft	15.76B
Raiffeisen Bank International AG	11.52B
BAWAG Group AG	9.04B
Strabag SE	9.00B
Vienna Insurance Group AG	6.54B
Voestalpine AG	6.37B

Market Cap Rankings